ERDERA
ERDERA Clinical Trial Call 2026 (pre-announcement)
Two-stage call — pre-proposal deadline shown; full-proposal deadline 2027-09-30
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
The ERDERA Clinical Trial Call 2026 funds consortium-based clinical trials, pre-announced under the European Rare Disease Research Alliance (ERDERA). The call runs as a two-stage process, with a pre-proposal submission in October 2026 followed by a full-proposal stage in September 2027, and is open to research teams working on rare disease clinical trials that can form the required consortium.
Details
| Funder | ERDERA |
| Deadline | 29 October 2026 |
| Consortium | Required |
| Application | Pre-proposal submission: 2026-10-29; Full-proposal submission: 2027-09-30 |
Eligibility & scope
ERDERA Clinical Trial Call 2026 (pre-announcement), listed under ERDERA on the ERA-LEARN call calendar. See the call guidance for funding, eligibility and consortium requirements.
Who Should Apply
- •Research teams planning clinical trials in rare diseases
- •Consortia able to meet ERDERA's required partnership structure
- •Applicants prepared for a two-stage submission process spanning almost a year
- •Institutions engaged in rare disease research networks under ERA-LEARN
Key Dates
- •Pre-proposal deadline: 29 October 2026
- •Full-proposal deadline: 30 September 2027
- •Two-stage application process (pre-proposal, then full proposal)
Tips for Applicants
- ✓This is a pre-announcement, check ERA-LEARN and ERDERA channels for the full call text before assembling a consortium.
- ✓With nearly a year between pre-proposal and full-proposal stages, use the gap to firm up consortium roles and trial design rather than rushing the initial submission.
- ✓Confirm exact funding amounts and eligibility rules in the official call guidance, since the pre-announcement does not fix these details.
Frequently Asked Questions
When is the ERDERA Clinical Trial Call 2026 deadline?
The pre-proposal deadline is 29 October 2026, with a full-proposal deadline of 30 September 2027 for those invited to the second stage.
Is the ERDERA Clinical Trial Call 2026 a two-stage call?
Yes, it requires a pre-proposal submission followed by a full-proposal submission almost a year later.
Do I need a consortium to apply to the ERDERA Clinical Trial Call 2026?
Yes, a consortium is required, though the call guidance should be checked for specific composition rules.
What does the ERDERA Clinical Trial Call 2026 fund?
It funds clinical trials under the European Rare Disease Research Alliance (ERDERA), as listed on the ERA-LEARN call calendar.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
SBEP Fourth Joint Call - 2026 (preannouncement)
SBEPDeadline: 16 Nov 2026DUT Call 2026
DUTDeadline: 17 Nov 2026M-ERA.NET Joint Call 2026
M-ERA.NETDeadline: 18 Nov 2026ERDERA Clinical Trial Call
Fondazione TelethonDeadline: 16 Nov 2026FORESTPathways
FORESTDeadline: 2 Dec 2026
Browse Related
Could ERDERA Clinical Trial Call 2026 (pre-announcement) be right for you?
Closes in 4 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →